2-127701590-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_032740.4(SFT2D3):c.62C>A(p.Ala21Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000015 in 1,330,610 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032740.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SFT2D3 | NM_032740.4 | c.62C>A | p.Ala21Glu | missense_variant | 1/1 | ENST00000310981.6 | NP_116129.3 | |
WDR33 | NM_018383.5 | c.*4733G>T | 3_prime_UTR_variant | 22/22 | ENST00000322313.9 | NP_060853.3 | ||
WDR33 | XM_011511436.2 | c.*4733G>T | 3_prime_UTR_variant | 22/22 | XP_011509738.1 | |||
WDR33 | XM_005263697.4 | c.*4903G>T | 3_prime_UTR_variant | 21/21 | XP_005263754.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SFT2D3 | ENST00000310981.6 | c.62C>A | p.Ala21Glu | missense_variant | 1/1 | 6 | NM_032740.4 | ENSP00000310803.3 | ||
WDR33 | ENST00000322313 | c.*4733G>T | 3_prime_UTR_variant | 22/22 | 1 | NM_018383.5 | ENSP00000325377.3 |
Frequencies
GnomAD3 genomes AF: 0.00000668 AC: 1AN: 149714Hom.: 0 Cov.: 34
GnomAD4 exome AF: 8.47e-7 AC: 1AN: 1180896Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 577934
GnomAD4 genome AF: 0.00000668 AC: 1AN: 149714Hom.: 0 Cov.: 34 AF XY: 0.0000137 AC XY: 1AN XY: 73190
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 04, 2024 | The c.62C>A (p.A21E) alteration is located in exon 1 (coding exon 1) of the SFT2D3 gene. This alteration results from a C to A substitution at nucleotide position 62, causing the alanine (A) at amino acid position 21 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at